Structure-Based Design and Synthesis of a Potent Matrix Metalloproteinase-13 Inhibitor Based on a Pyrrolidinone Scaffold
- 27 May 2000
- journal article
- letter
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 43 (12) , 2293-2296
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Homology Modeling of Gelatinase Catalytic Domains and Docking Simulations of Novel Sulfonamide InhibitorsJournal of Medicinal Chemistry, 1999
- Rational Design and Combinatorial Evaluation of Enzyme Inhibitor Scaffolds: Identification of Novel Inhibitors of Matrix MetalloproteinasesJournal of Medicinal Chemistry, 1998
- Matrix metalloproteinase inhibitors 1998Expert Opinion on Therapeutic Patents, 1998
- Discovery of CGS 27023A, a Non-Peptidic, Potent, and Orally Active Stromelysin Inhibitor That Blocks Cartilage Degradation in RabbitsJournal of Medicinal Chemistry, 1997
- Stromelysin‐1: Three‐dimensional structure of the inhibited catalytic domain and of the C‐truncated proenzymeProtein Science, 1995
- Structure determination and analysis of human neutrophil collagenase complexed with a hydroxamate inhibitorBiochemistry, 1995
- Crystal structures of matrilysin-inhibitor complexesBiochemistry, 1995
- Synthesis of hydroxamic acids: as a new catalyst for the deprotection of O-benzyl hydroxamatesTetrahedron Letters, 1995
- The X‐ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity.The EMBO Journal, 1994
- Structure of the Catalytic Domain of Fibroblast Collagenase Complexed with an InhibitorScience, 1994